Winslow Evans & Crocker’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$33K Sell
1,624
-100
-6% -$2.09K 0.01% 683
2020
Q3
$42K Sell
1,724
-148
-8% -$3.46K 0.01% 491
2020
Q2
$44K Buy
1,872
+36
+2% +$834 0.01% 479
2020
Q1
$32K Hold
1,836
0.01% 505
2019
Q4
$34K Sell
1,836
-164
-8% -$2.78K 0.01% 571
2019
Q3
$36K Buy
2,000
+20
+1% +$405 0.01% 554
2019
Q2
$44K Buy
1,980
+140
+8% +$2.93K 0.01% 537
2019
Q1
$44K Buy
1,840
+214
+13% +$4.88K 0.01% 519
2018
Q4
$32K Hold
1,626
0.01% 537
2018
Q3
$30K Hold
1,626
0.01% 581
2018
Q2
$36K Hold
1,626
0.01% 556
2018
Q1
$36K Buy
1,626
+126
+8% +$3.48K 0.01% 547
2017
Q4
$45.6K Buy
+1,500
New +$39.9K 0.01% 511

Other funds holding EXEL

Winslow Evans & Crocker's EXEL Position: Q4 2020 in Review

Winslow Evans & Crocker reduced its Exelixis (EXEL) stake by 5.8% in Q4 2020, selling an estimated $2.09K and leaving 1,624 shares worth $33K. The position accounts for 0.01% of the portfolio, ranked #683.

Winslow Evans & Crocker first reported a position in EXEL in Q4 2017 and has held it in 13 quarters since. The position peaked at $45.6K in Q4 2017. 351 funds tracked by Wall St. Rank hold EXEL as of Q4 2020.

  • Winslow Evans & Crocker held 1,624 shares of Exelixis worth $33K as of Q4 2020.
  • Winslow Evans & Crocker sold 100 Exelixis shares in Q4 2020, an estimated $2.09K.
  • Exelixis made up 0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #683 holding.
  • Winslow Evans & Crocker first reported a position in Exelixis in Q4 2017 and has held it in 13 quarters since.
  • Winslow Evans & Crocker's Exelixis position peaked at $45.6K in Q4 2017.
  • 351 funds tracked by Wall St. Rank held Exelixis as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.